hasTargetDisease
P20980
predicate
Indicates that an entity (such as a treatment, study, or intervention) is directed toward, intended to affect, or primarily concerned with a specified disease.
All labels observed (20)
| Label | Occurrences |
|---|---|
| therapeuticArea | 219 |
| hasTherapeuticArea | 67 |
| targetsDisease | 20 |
| targetDisease | 18 |
| studiesDisease | 8 |
| diseaseArea | 6 |
| therapeuticTargetIn | 5 |
| surveillanceFocusDiseases | 4 |
| diseaseTarget | 3 |
| diseaseTargeted | 2 |
| hasFocusDisease | 2 |
| treatsDiseaseArea | 2 |
| actsOnDisease | 1 |
| combinedWithFlucytosineUsedFor | 1 |
| coveredDisease | 1 |
| diseaseBurdenAddressed | 1 |
| hasFDAIndicationText | 1 |
| hasPrimaryDiseaseFocus | 1 |
| hasTargetDisease canonical | 1 |
| relatedToDisease | 1 |
Description generation (PDg)
The one-sentence description above was generated by prompting gpt-5.1 with the predicate name and this instruction.
Instruction
Given a predicate that represents a relationship or action between entities, generate a one-sentence description explaining its meaning. # Instructions Focus on describing the relationship, not the entities themselves. # Response Format Begin the description with \' Indicates...\'
Input
Predicate: hasTargetDisease
Generated description
Indicates that an entity (such as a treatment, study, or intervention) is directed toward, intended to affect, or primarily concerned with a specified disease.
Sample triples (364)
| Subject | Object |
|---|---|
| Advance Market Commitment for pneumococcal vaccines | pneumococcal disease ⓘ |
| Leqembi | treatment of Alzheimer’s disease via predicate surface "hasFDAIndicationText" ⓘ |
| Spinraza | neurology via predicate surface "hasTherapeuticArea" ⓘ |
| Spinraza | rare diseases via predicate surface "hasTherapeuticArea" ⓘ |
| Eisai | central nervous system disorders via predicate surface "hasTherapeuticArea" ⓘ |
| Eisai | epilepsy via predicate surface "hasTherapeuticArea" ⓘ |
| Eisai | solid tumors via predicate surface "hasTherapeuticArea" ⓘ |
| Eisai | hematologic malignancies via predicate surface "hasTherapeuticArea" ⓘ |
| Action and Investment to defeat Malaria | vector-borne diseases via predicate surface "diseaseArea" ⓘ |
| Fampyra | neurology via predicate surface "therapeuticArea" ⓘ |
| Diabetes Group | endocrinology via predicate surface "therapeuticArea" ⓘ |
| Diabetes Group | metabolic diseases via predicate surface "therapeuticArea" ⓘ |
| Lucentis | ophthalmology via predicate surface "hasTherapeuticArea" ⓘ |
| Tecentriq | oncology via predicate surface "therapeuticArea" ⓘ |
| Tecentriq | immuno-oncology via predicate surface "therapeuticArea" ⓘ |
| Janssen COVID-19 Vaccine |
COVID-19
via predicate surface "targetDisease"
ⓘ
linked to:
COVID-19 vaccines
|
| Guinea Worm Eradication Program | dracunculiasis via predicate surface "targetDisease" ⓘ |
| Guinea Worm Eradication Program | Guinea worm disease via predicate surface "targetDisease" ⓘ |
| River Blindness Program | river blindness via predicate surface "targetsDisease" ⓘ |
| River Blindness Program | onchocerciasis via predicate surface "targetsDisease" ⓘ |
| Trachoma Control Program | trachoma via predicate surface "targetsDisease" ⓘ |
| rVSV-ZEBOV | Ebola virus disease via predicate surface "targetDisease" ⓘ |
| PolioPlus | poliomyelitis via predicate surface "targetDisease" ⓘ |
| MRC Protein Phosphorylation and Ubiquitylation Unit | cancer via predicate surface "studiesDisease" ⓘ |
| MRC Protein Phosphorylation and Ubiquitylation Unit | neurodegenerative diseases via predicate surface "studiesDisease" ⓘ |
| MRC Protein Phosphorylation and Ubiquitylation Unit | inflammatory diseases via predicate surface "studiesDisease" ⓘ |
| MRC Protein Phosphorylation and Ubiquitylation Unit | metabolic disorders via predicate surface "studiesDisease" ⓘ |
| MRC Protein Phosphorylation and Ubiquitylation Unit | rare genetic disorders affecting signaling pathways via predicate surface "studiesDisease" ⓘ |
| Butembo Health Zone | Ebola virus disease via predicate surface "surveillanceFocusDiseases" ⓘ |
| Butembo Health Zone | measles via predicate surface "surveillanceFocusDiseases" ⓘ |
| Butembo Health Zone | cholera via predicate surface "surveillanceFocusDiseases" ⓘ |
| Butembo Health Zone | malaria via predicate surface "surveillanceFocusDiseases" ⓘ |
| REGN-EB3 | Ebola virus disease via predicate surface "targetDisease" ⓘ |
| REGN-EB3 | infectious disease via predicate surface "therapeuticArea" ⓘ |
| REGN-EB3 | virology via predicate surface "therapeuticArea" ⓘ |
| MedImmune | infectious diseases via predicate surface "therapeuticArea" ⓘ |
| MedImmune | oncology via predicate surface "therapeuticArea" ⓘ |
| MedImmune | respiratory diseases via predicate surface "therapeuticArea" ⓘ |
| MedImmune | autoimmune and inflammatory diseases via predicate surface "therapeuticArea" ⓘ |
| AstraZeneca | oncology via predicate surface "therapeuticArea" ⓘ |
| AstraZeneca | cardiovascular via predicate surface "therapeuticArea" ⓘ |
| AstraZeneca | renal via predicate surface "therapeuticArea" ⓘ |
| AstraZeneca | metabolism via predicate surface "therapeuticArea" ⓘ |
| AstraZeneca | respiratory via predicate surface "therapeuticArea" ⓘ |
| AstraZeneca | immunology via predicate surface "therapeuticArea" ⓘ |
| AstraZeneca | rare diseases via predicate surface "therapeuticArea" ⓘ |
| COVID-19 vaccines |
COVID-19
via predicate surface "targetDisease"
ⓘ
linked to:
COVID-19 pandemic
|
| CLARITY AD | neurology via predicate surface "therapeuticArea" ⓘ |
| CLARITY AD | neurodegenerative disease via predicate surface "therapeuticArea" ⓘ |
| Eisai and Biogen |
Alzheimer’s disease
via predicate surface "therapeuticArea"
ⓘ
linked to:
Alzheimer's disease
|